(Q36597619)

15 August 2017

1 reference

title

Genetic screening by DNA technology: a systematic review of health economic evidence (English)

1 reference

15 August 2017

1 reference

Wolf Rogowski

1

1 reference

15 August 2017

publication date

1 January 2006

1 reference

International Journal of Technology Assessment in Health Care

15 August 2017

published in

1 reference

15 August 2017

volume

22

1 reference

15 August 2017

issue

3

1 reference

15 August 2017

page(s)

327-337

1 reference

Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Searching literature databases for health care economic evaluations: how systematic can we afford to be?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Neonatal biochemical screening for disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Development and validation of a grading system for the quality of cost-effectiveness studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Economic evaluations of screening programs: a review of methods and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Statistical approaches to handling uncertainty in health economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

A systematic review of cost-effectiveness analyses of pharmacogenomic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Cost-effectiveness of a family and DNA based screening programme on familial hypercholesterolaemia in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Cost effectiveness of a new strategy to identify HNPCC patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Population screening in the age of genomic medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Quality of economic evaluations in health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Genetic counseling program in familial breast cancer: Analysis of its effectiveness, cost and cost-effectiveness ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

7 January 2021

Guides for reading and interpreting systematic reviews: I. Getting started

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

7 January 2021

Public health impact of genetic tests at the end of the 20th century

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

7 January 2021

Costs of predicting IDDM

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

7 January 2021

Benefits and costs of screening Ashkenazi Jewish women for BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

7 January 2021

Grading systems for cost-effectiveness studies: is the whole greater than the sum of the parts?

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

7 January 2021

Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

7 January 2021

Cost analysis of alternative approaches to colorectal screening in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

7 January 2021

Genotype-based screening for hereditary haemochromatosis. I: Technical performance, costs and clinical relevance of a German pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS0266462306051221

7 January 2021

10.1017/S0266462306051221

Identifiers

DOI

1 reference

15 August 2017

1 reference